Table 1 Indications for HSCT (pre-HSCT group)
From: Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation
Diagnosis | Number (%) |
|---|---|
Acute lymphoblastic leukemia (ALL) | 11 (40.7) |
Acute myeloblastic leukemia (AML) | 4 (14.8) |
Chronic myelocytic leukemia (CML) | 1 (3.6) |
Myelodysplastic syndrome (MDS) | 1 (3.6) |
Juvenile myelomonocytic leukemia (JMML) and AML | 1 (3.6) |
Neoplastic diseases – total | 18 (70) |
Severe aplastic anemia (SAA) | 4 (14.8) |
Chronic granulomatous disease (CGD) | 3 (8) |
Autoimmune lymphoproliferative syndrome (ALPS) | 1 (3.6) |
Hyper IgM syndrome (HIgM) | 1 (3.6) |
Non-neoplastic diseases – total | 9 (30) |